Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia

Published:2012-02-23 Issue:1 Volume:40 Page:133-142
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:Eur Respir J

Author:

Floyd Katherine,Hutubessy Raymond,Kliiman Kai,Centis Rosella,Khurieva Nina,Jakobowiak Wieslaw,Danilovits Manfred,Peremitin Genadi,Keshavjee Salmaan,Migliori Giovanni Battista

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rethinking Tuberculosis Morbidity Quantification: A Systematic Review and Critical Appraisal of TB Disability Weights in Cost-Effectiveness Analyses;PharmacoEconomics;2024-08-07

2. Correlation between heart rate variability and perioperative neurocognitive disorders in patients undergoing non-cardiac surgery: A retrospective cohort study;PLOS ONE;2024-04-02

3. Cost-consequence analysis of ambulatory clinic- and home-based multidrug-resistant tuberculosis management models in Eswatini;PLOS ONE;2024-04-02

4. Costs of services and funding gap of the Bangladesh National Tuberculosis Control Programme 2016–2022: An ingredient based approach;PLOS ONE;2023-06-02

5. Impact of financial support on treatment outcomes of multidrug-resistant tuberculosis: a population-based, retrospective cohort study in China;2022-11-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP